Avita Medical
1st Floor, Unex House
132-134 Hills Road
Cambridge
CB2 8PA
United Kingdom
Tel: 44-0-1223 341150
Fax: 44-0-1223-341170
Website: http://www.avitamedical.com/
Email: info.eu@avitamedical.com
276 articles about Avita Medical
-
Avita Medical Granted CE Mark For Expanded ReCell
4/27/2015
-
Avita Medical Hosts International Skin Regeneration Symposium Attended By Leading Clinicians
4/24/2015
-
Avita Medical Appoints a New CEO
4/14/2015
-
Avita Medical Announces First Patient Enrollment In US Pivotal Study Of Recell® For The Treatment Of Burns
1/28/2015
-
UPDATE - Avita Medical Provides National Institute for Clinical Excellence (NICE) Guidance Recommendation Update
11/13/2014
-
Avita Medical Announces Receipt Of $1.4 Million R&D Tax Incentive
11/11/2014
-
Avita Medical (ASX:AVH) (AVMXY) Announces Comprehensive Participation At International Society Of Burn Injuries' 17th Biennial Congress Showcasing Recell(R) Technology
10/10/2014
-
Avita Medical Secures U.S. FDA Approval To Modify ReCell® Clinical Burns Trial
9/17/2014
-
Avita Medical (ASX:AVH) New Chairman And Board Changes
7/1/2014
-
Avita Medical Presents More Positive ReCell Repigmentation Trial Results
6/11/2014
-
Avita Medical Appoints New Chairman
5/20/2014
-
FDA Release: Avita Medical Grants An Investigational Device Exemption For Compassionate Use Of ReCell
4/10/2014
-
Avita Medical Release: ReCell Containing Ambient-Stored Enzyme Launched In United Kingdom And Europe
4/9/2014
-
Avita Medical CEO Steps Down After First Strike, Interim Chief Named
12/12/2013
-
Avita Medical Announces Completion of Enrollment in ReCell® Trial for Vitiligo
8/21/2013
-
Avita Medical Enrolls First Patients in ReCell® Trial for Chronic Leg Ulcers
8/1/2013
-
Avita Medical Release: Granted Japanese Patent Expands Commercial Rights for ReCell® Spray-On Skin® Technology in Asia
4/10/2013
-
Avita Medical Skin Regeneration Symposium Attracts Top European Surgeons
3/28/2013
-
Avita Medical Completes ISO Quality Audit, CE Mark Recertification
2/14/2013
-
Avita Medical CEO William Dolphin, Ph.D. Interviewed by Stock News Now
2/14/2013